Literature DB >> 9331348

Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III.

H Chen1, A Chédotal, Z He, C S Goodman, M Tessier-Lavigne.   

Abstract

Semaphorins are a large family of secreted and transmembrane proteins, several of which are implicated in repulsive axon guidance. Neuropilin (neuropilin-1) was recently identified as a receptor for Collapsin-1/Semaphorin III/D (Sema III). We report the identification of a related protein, neuropilin-2, whose mRNA is expressed by developing neurons in a pattern largely, though not completely, nonoverlapping with that of neuropilin-1. Unlike neuropilin-1, which binds with high affinity to the three structurally related semaphorins Sema III, Sema E, and Sema IV, neuropilin-2 shows high affinity binding only to Sema E and Sema IV, not Sema III. These results identify neuropilins as a family of receptors (or components of receptors) for at least one semaphorin subfamily. They also suggest that the specificity of action of different members of this subfamily may be determined by the complement of neuropilins expressed by responsive cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9331348     DOI: 10.1016/s0896-6273(00)80371-2

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  173 in total

1.  Myelin and collapsin-1 induce motor neuron growth cone collapse through different pathways: inhibition of collapse by opposing mutants of rac1.

Authors:  T B Kuhn; M D Brown; C L Wilcox; J A Raper; J R Bamburg
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

2.  The semaphorin receptor plexin-B1 specifically interacts with active Rac in a ligand-dependent manner.

Authors:  H G Vikis; W Li; Z He; K L Guan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

Review 3.  Turning heads: development of vertebrate branchiomotor neurons.

Authors:  Anand Chandrasekhar
Journal:  Dev Dyn       Date:  2004-01       Impact factor: 3.780

Review 4.  Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer.

Authors:  Atsuko Sakurai; Colleen L Doçi; Colleen Doci; J Silvio Gutkind
Journal:  Cell Res       Date:  2011-12-13       Impact factor: 25.617

Review 5.  Semaphorins in angiogenesis and tumor progression.

Authors:  Gera Neufeld; Adi D Sabag; Noa Rabinovicz; Ofra Kessler
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 6.  Signal transduction by vascular endothelial growth factor receptors.

Authors:  Sina Koch; Lena Claesson-Welsh
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

7.  Zbtb20 is essential for the specification of CA1 field identity in the developing hippocampus.

Authors:  Zhifang Xie; Xianhua Ma; Wenli Ji; Guangdi Zhou; Yinzhong Lu; Zhenghua Xiang; Yan X Wang; Lei Zhang; Yiping Hu; Yu-Qiang Ding; Weiping J Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-22       Impact factor: 11.205

8.  Expression by midbrain dopamine neurons of Sema3A and 3F receptors is associated with chemorepulsion in vitro but a mild in vivo phenotype.

Authors:  Enrique R Torre; Claire-Anne Gutekunst; Robert E Gross
Journal:  Mol Cell Neurosci       Date:  2010-03-16       Impact factor: 4.314

9.  Neuropilin-2 contributes to tumorigenicity in a mouse model of Hedgehog pathway medulloblastoma.

Authors:  Melanie G Hayden Gephart; YouRong Sophie Su; Samuel Bandara; Feng-Chiao Tsai; Jennifer Hong; Nicholas Conley; Helen Rayburn; Ljiljana Milenkovic; Tobias Meyer; Matthew P Scott
Journal:  J Neurooncol       Date:  2013-09-12       Impact factor: 4.130

10.  Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding.

Authors:  Brent A Appleton; Ping Wu; Janice Maloney; JianPing Yin; Wei-Ching Liang; Scott Stawicki; Kyle Mortara; Krista K Bowman; J Michael Elliott; William Desmarais; J Fernando Bazan; Anil Bagri; Marc Tessier-Lavigne; Alexander W Koch; Yan Wu; Ryan J Watts; Christian Wiesmann
Journal:  EMBO J       Date:  2007-11-08       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.